Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Quarterly results in brief
(Rs crore)
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Sales

305.79 311.07 295.47 284.70 249.81

Operating profit

15.06 52.76 67.25 59.85 36.59

Interest

0.61 0.50 0.15 0.09 0.20

Gross profit

24.10 60.63 75.20 67.76 43.59

EPS (Rs)

6.32 20.95 21.54 6.91 11.72
Quarterly  results in details
Dec' 23 Sep' 23 Jun' 23 Mar' 23 Dec' 22

Other income

9.66 8.37 8.10 8.00 7.20

Stock adjustment

-70.76 -56.62 -11.34 -26.70 -9.88

Raw material

37.52 38.80 19.08 21.62 27.10

Power and fuel

- - - - -

Employee expenses

63.23 65.27 54.97 66.86 62.68

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

260.74 210.86 165.51 163.08 133.31

Provisions made

- - - - -

Depreciation

3.70 3.67 3.80 4.25 4.13

Taxation

4.60 21.01 17.54 6.01 10.15

Net profit / loss

15.80 52.37 53.86 17.27 29.30

Extra ordinary item

- 16.43 - -40.23 -

Prior year adjustments

- - - - -

Equity capital

5.00 5.00 5.00 5.00 5.00

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

4.92 16.96 22.76 21.02 14.65

GPM (%)

7.64 18.98 24.77 23.15 16.96

NPM (%)

5.01 16.39 17.74 5.90 11.40
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com